603439.SH
GuiZhou SanLi Pharmaceutical Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 11.25
+3.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 29.47x
- P/E 2027E
- 27.21x
- P/E 2028E
- —
- P/S forward
- 5.24x
Trailing multiples
Trailing twelve months
- P/E TTM
- 98.22x
- PEG TTM
- —
- Price / book
- 2.99x
- Price / sales
- 2.56x
- Price / cash flow
- 22.17x
Enterprise value
- Enterprise value
- CNY 4.8B
- EV / sales
- 2.86x
- EV / EBITDA
- 34.86x
- EV / EBIT
- 69.76x
- Market cap
- CNY 4.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026